Dordaviprone (ONC201)
ONC201-108
Phase 3 small_molecule active
Quick answer
Dordaviprone (ONC201) for H3 K27M is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- H3 K27M
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active